Gates Foundation pledges $120M to support access for Covid-19 pill

To address ongoing Covid-19 infections in low-income countries, The Bill & Melinda Gates Foundation is donating $120 million to increase access to molnupiravir, an antiviral pill. Headquartered in Seattle, The Bill & Melinda Gates Foundation has committed more than $1.9 billion toward covid vaccines, tests and treatments since the pandemic began.

“To end this pandemic, we need to ensure that everyone, no matter where they live in the world, has access to life-saving health products. The unjust reality, however, is that low-income countries have had to wait for everything from personal protective equipment to vaccines,” said Melinda French Gates, Gates Foundation co-chair.

READ THE STORY at Puget Sound Business Journal »